Search

everythinglearnresearchcommunity

for

Search:↓

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Women with PCOS often have sleep and mental health issues, especially if overweight or insulin resistant.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

A supplement with Serenoa repens improved hair loss in a patient.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

In Freixo de Espada à Cinta, many people have skin lesions, especially moles and acne.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

A community dermatology event in Delhi showed a high need for follow-up and awareness about skin conditions.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Coping style affects mental health and quality of life in Indian women with PCOS.

Lower SHBG levels may increase the risk of PCOS.

Genetic screening can help diagnose and manage infertility in Slovenian couples.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

COVID-19 increased hair loss cases, but vaccination did not.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Many COVID-19 survivors still face health issues months later, so ongoing medical support is important.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

HPV vaccines are generally safe but need further investigation for rare side effects.

Ankylosing spondylitis does not increase the risk of hair loss.